Back

Frequent need for apixaban dose adjustment for atrial fibrillation in an unselected acute medical admission population during the COVID 19 pandemic.

1 December 2022 (13:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 1 Prevention ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Doctor Khin Kay Kay Kyaw

University Hospitals Plymouth NHS Trust, Plymouth (United Kingdom of Great Britain & Northern Ireland)

27 More presentations in this session

Presentation thumbnail
The use of hatch score for the prediction of post operative atrial fibrillation (poaf) after coronary artery bypass graft: a meta-analysis
Doctor A. Ramos (Muntinlupa, PH)
Abstract Slides
Presentation thumbnail
Relationship and outcomes between volume status, cardiac and renal dysfunction in patients with chronic heart failure.
Doctor A. Challa (Rochester, US)
Abstract Slides
Presentation thumbnail
Association between triglyceride and all-cause mortality and cardiovascular outcomes in heart failure patients: a territory-wide study in Hong Kong
Mrs Q. Ren (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
Effects of SGLT2 inhibitors on heart failure symptoms, quality of life and exercise capacity in patients with heart failure and preserved ejection fraction: A meta-analysis
Doctor L. Merin (Cebu City, PH)
Abstract Slides
Presentation thumbnail
Incident heart failure and the subsequent risk for progression to end stage kidney disease in South East Asian people with type 2 diabetes
Ms S. L (Singapore, SG)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1

The Event

Event poster

ESC Asia 2022 with APSC & AFC

1 December 2022 13:00 CET
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources